Sabby Management, LLC Tricida, Inc. Transaction History

Sabby Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$4.19 - $9.56 $1.99 Million - $4.54 Million	-475,000 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$3.56 - $4.64 $137,060 - $178,640	38,500 Added 8.82%	475,000 $2.2 Million
Q2 2021 Aug 16, 2021	BUY	$3.95 - $5.41 $322,892 - $442,240	81,745 Added 23.04%	436,500 $1.89 Million
Q1 2021 May 17, 2021	BUY	$4.52 - $7.8 $697,517 - $1.2 Million	154,318 Added 76.99%	354,755 $1.88 Million
Q4 2020 Feb 16, 2021	BUY	$4.37 - $9.46 $875,909 - $1.9 Million	200,437 New	200,437 $1.41 Million

30K

124K

46.5K

Ticker TCDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,668,900
Market Cap $557K
Description
Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of veverimer (TRC101), a non-absorbed orally-administered polymer that has completed Phase III trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company ...

Get notified when there are updates to the investment portfolio of Sabby Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sabby Management, LLC with notifications on news.